<DOC>
	<DOCNO>NCT01067794</DOCNO>
	<brief_summary>This observational study plan , primary objective observe patient survival follow first-line treatment patient Stage IIIB/IV Non-small Cell Lung Cancer ( NSCLC ) different platinum-based doublet routine disease management condition . Further secondary objective study provide insight extent histologic subtyping use additional prognostic predictive biomarkers currently consider differential therapeutic decision routine condition . All data critical evaluate factor differential therapeutic decision effect patient outcome real life setting , obtain observational research .</brief_summary>
	<brief_title>Chemotherapy Treating Patients With Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<criteria>Histological cytological diagnosis nonsmall cell lung cancer ( NSCLC ) stage IIIBIV Initiation firstline treatment advance NSCLC platinumbased doublet chemotherapy , without additional target agent 18 year age old Participating simultaneously study include administration investigational drug procedure entry study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Metastatic</keyword>
	<keyword>Advanced</keyword>
	<keyword>Stage IIIB-IV</keyword>
	<keyword>daily</keyword>
	<keyword>hospital</keyword>
	<keyword>practice</keyword>
	<keyword>set</keyword>
</DOC>